Catalyst Wire Dossier Catalyst Wire Dossier

SPRAVATO

ESKETAMINE HYDROCHLORIDE · Janssen Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

54 regulatory and trial events tracked for SPRAVATO, covering 2013-01-29 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder [NA]

See pricing